Editorial
Biosimilars, a new era in rheumatology in Spain
Los biosimilares, una nueva era en la reumatología en España
Read
5929
Timeswas read the article
1757
Total PDF
4172
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 7 | 11 | 18 |
| 2025 5 | 199 | 61 | 260 |
| 2025 4 | 181 | 31 | 212 |
| 2025 3 | 157 | 24 | 181 |
| 2025 2 | 136 | 35 | 171 |
| 2025 1 | 115 | 29 | 144 |
| 2024 12 | 113 | 35 | 148 |
| 2024 11 | 84 | 69 | 153 |
| 2024 10 | 92 | 25 | 117 |
| 2024 9 | 102 | 22 | 124 |
| 2024 8 | 124 | 34 | 158 |
| 2024 7 | 113 | 25 | 138 |
| 2024 6 | 91 | 30 | 121 |
| 2024 5 | 97 | 26 | 123 |
| 2024 4 | 92 | 22 | 114 |
| 2024 3 | 79 | 24 | 103 |
| 2024 2 | 81 | 33 | 114 |
| 2024 1 | 64 | 26 | 90 |
| 2023 12 | 64 | 23 | 87 |
| 2023 11 | 69 | 29 | 98 |
| 2023 10 | 74 | 26 | 100 |
| 2023 9 | 88 | 36 | 124 |
| 2023 8 | 98 | 23 | 121 |
| 2023 7 | 72 | 19 | 91 |
| 2023 6 | 52 | 23 | 75 |
| 2023 5 | 76 | 27 | 103 |
| 2023 4 | 110 | 11 | 121 |
| 2023 3 | 106 | 26 | 132 |
| 2023 2 | 65 | 28 | 93 |
| 2023 1 | 59 | 27 | 86 |
| 2022 12 | 64 | 29 | 93 |
| 2022 11 | 54 | 32 | 86 |
| 2022 10 | 66 | 32 | 98 |
| 2022 9 | 44 | 20 | 64 |
| 2022 8 | 31 | 37 | 68 |
| 2022 7 | 54 | 33 | 87 |
| 2022 6 | 39 | 33 | 72 |
| 2022 5 | 53 | 44 | 97 |
| 2022 4 | 70 | 39 | 109 |
| 2022 3 | 54 | 51 | 105 |
| 2022 2 | 62 | 37 | 99 |
| 2022 1 | 59 | 32 | 91 |
| 2021 12 | 61 | 34 | 95 |
| 2021 11 | 45 | 40 | 85 |
| 2021 10 | 55 | 44 | 99 |
| 2021 9 | 44 | 41 | 85 |
| 2021 8 | 42 | 32 | 74 |
| 2021 7 | 35 | 17 | 52 |
| 2021 6 | 36 | 27 | 63 |
| 2021 5 | 42 | 29 | 71 |
| 2021 4 | 92 | 81 | 173 |
| 2021 3 | 61 | 18 | 79 |
| 2021 2 | 27 | 15 | 42 |
| 2021 1 | 25 | 22 | 47 |
| 2020 12 | 29 | 14 | 43 |
| 2020 11 | 21 | 21 | 42 |
| 2020 10 | 16 | 21 | 37 |
| 2020 9 | 29 | 20 | 49 |
| 2020 8 | 2 | 2 | 4 |
Show all
